Allied Biotech Corporation announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 365.840 million compared to TWD 431.200 million a year ago. Operating income was TWD 82.482 million compared to TWD 93.437 million a year ago. Net income was TWD 84.034 million compared to TWD 83.464 million a year ago. Basic earnings per share was TWD 0.89 compared to TWD 0.88 a year ago.